Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.03.2023 | Case report

Acalabrutinib/ibrutinib

Atrial fibrillation, complete heart block and bleeding : case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ikram M, et al. SARCOID LYMPHOMA SYNDROME: THE DISCOVERY OF CARDIAC SARCOIDOSIS DURING THERAPY FOR CHRONIC LYMPHOCYTIC LEUKEMIA, SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL). Journal of the American College of Cardiology 81 (Suppl.): 2971 (plus poster) abstr. 1346-109, No. 8, et al. Mar 2023. Available from: URL: http://doi.org/10.1016/S0735-1097%2823%2903415-0 [abstract] Ikram M, et al. SARCOID LYMPHOMA SYNDROME: THE DISCOVERY OF CARDIAC SARCOIDOSIS DURING THERAPY FOR CHRONIC LYMPHOCYTIC LEUKEMIA, SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL). Journal of the American College of Cardiology 81 (Suppl.): 2971 (plus poster) abstr. 1346-109, No. 8, et al. Mar 2023. Available from: URL: http://​doi.​org/​10.​1016/​S0735-1097%2823%2903415-0 [abstract]
Metadaten
Titel
Acalabrutinib/ibrutinib
Atrial fibrillation, complete heart block and bleeding : case report
Publikationsdatum
01.03.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-35996-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Antineoplastics